Using patient-reported outcomes (PROs) provides important insights from the patient's perspective and can be valuable to monitor and manage treatment-related adverse events during cancer treatment.
Patient access to innovative new therapies requires us to reimagine the supply chain and how it integrates advanced technologies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback